BLCO
HEALTHCAREBausch + Lomb Corp
$16.00+0.00 (+0.00%)PRE
Live · NYSE · May 9, Close
AI Insight
What's Moving BLCO Today?
No stock-specific AI insight has been generated for BLCO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$10.99$18.91
$16.00
Fundamentals
Market Cap$5.7B
P/E Ratio—
EPS$-0.62
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin-0.1%
Debt / Equity—
Trading
Volume446K
Avg Volume (10D)—
Shares Outstanding356.5M
BLCO News
21 articles- Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in EuropeYahoo Finance·May 7, 2026
- Bausch + Lomb Announces Second R&D "Teach-in" WebinarYahoo Finance·May 6, 2026
- What Bausch + Lomb (BLCO)'s Upgraded 2026 Outlook and Narrowing Losses Mean For ShareholdersYahoo Finance·May 2, 2026
- Why Bausch Health Companies Was Crawling Higher This WeekMotley Fool·May 1, 2026
- Bausch + Lomb (BLCO) Q1 2026 Earnings TranscriptMotley Fool·Apr 30, 2026
- BHC Q1 Earnings Miss Estimates, Sales Grow on Salix & Solta StrengthYahoo Finance·Apr 30, 2026
- Bausch + Lomb Corporation Q1 2026 Earnings Call SummaryMoby·Apr 30, 2026
- Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual MeetingYahoo Finance·Apr 30, 2026
- Bausch Health Companies Inc (BHC) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...Yahoo Finance·Apr 30, 2026
- Bausch + Lomb Q1 Earnings Call HighlightsMarketbeat·Apr 30, 2026
- Bausch Health Cos Q1 Earnings Call HighlightsMarketbeat·Apr 30, 2026
- Bausch Health Q1 Adjusted Earnings, Revenue, Advance, Beating EstimatesYahoo Finance·Apr 29, 2026
- Bausch + Lomb (BLCO) Surpasses Q1 Earnings and Revenue EstimatesYahoo Finance·Apr 29, 2026
- Bausch + Lomb Swings to Q1 Adjusted Profit, Revenue upYahoo Finance·Apr 29, 2026
- Bausch + Lomb (NYSE:BLCO) Posts Better-Than-Expected Sales In Q1 CY2026Yahoo Finance·Apr 29, 2026
- Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive OutlookYahoo Finance·Apr 29, 2026
- Bausch + Lomb (BLCO) Q1 Earnings Report Preview: What To Look ForYahoo Finance·Apr 28, 2026
- Bausch Health's Q1 Total Prescriptions Hurt by Exit From Federal Drug Pricing Programs, RBC SaysYahoo Finance·Apr 27, 2026
- Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular DegenerationYahoo Finance·Apr 23, 2026
- Bausch Health (BHC) Q3 2024 Earnings TranscriptMotley Fool·Apr 22, 2026
- A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the StoryThe Motley Fool·Mar 24, 2026
All 21 articles loaded
Price Data
Open$16.20
Previous Close$16.00
Day High$16.20
Day Low$15.82
52 Week High$18.91
52 Week Low$10.99
52-Week Range
$10.99$18.91
$16.00
Fundamentals
Market Cap$5.7B
P/E Ratio—
EPS$-0.62
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin-0.1%
Debt / Equity—
Trading
Volume446K
Avg Volume (10D)—
Shares Outstanding356.5M
About Bausch + Lomb Corp
Bausch Lomb Corporation is an eye health company in Canada and internationally. The company is headquartered in Vaughan, Canada.
HEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Company Details
Security TypeStock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICMEDICAL INSTRUMENTS & SUPPLIES
CIK—
Composite FIGI—
Share Class FIGI—